Redenlab partners with BDCRC to support new NIH-funded Batten disease research
A newly formed research network focused on Batten disease, a rare and inherited brain disorder that primarily affects…
October 27, 2020 |
Redenlab – Global Experts
January 31, 2019 |
Redenlab commence collaboration with UCSF Memory and Aging Center
March 5, 2018 |
Redenlab sign agreement with Monash Institute of Cognitive and Clinical Neurosciences
August 18, 2017 |
Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis
July 31, 2017 |
Redenlab commence work with Melbourne Brain Centre & The University of Melbourne on speech testing for clinical trial in Dravet Syndrome
July 24, 2017 |
Redenlab sign contract with Koneksa Health & Takeda Pharmaceuticals
Latest News
Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection
Receiving the CUREator+ Dementia & Cognitive Decline funding marks a meaningful milestone in our journey to transform how…
CLOSED: Machine Learning Deployment Engineer
Redenlab is looking for a versatile Machine Learning Deployment Engineer with a strong background in both model operationalization and fine-tuning/training to help…
CLOSED: EA to CEO / Office Manager
Redenlab is looking for an experienced executive assistant and bookkeeper to assist in managing our day-to-day business activities…
Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research
Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research
People Who Stutter Create (PWSC) presents “Stuttering Can Create Time” as part of the Whitney Biennial 2024
Displayed at 95 Horatio Street, NY, PWSC argues that stuttering fosters deep listening and collaboration, aiming to transform…
Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases
MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a…
Childhood apraxia of speech clinical trial
Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic…
Researchers working towards finding a new treatment for Spinocerebellar Ataxia Type 1 (SCA1)
Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination…
The FA App
Friedreich ataxia (FA) is a progressive, genetically inherited multisystem disease that affects children and adults. FA leads to…
TRACK-FA Study
Friedreich ataxia (FA) is an inherited, multisystem neurodegenerative disease that results in profound changes to speech, swallowing, balance,…
Professor Angela Morgan leads the Translational Centre for Speech Disorders in groundbreaking NHMRC CRE research program
Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that…
Academic and patient advocacy group collaborations in Dentatorubral-pallidoluysian atrophy (DRPLA)
Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA…
Redenlab welcomes Dr. Peter Gibilisco to our advisory board, reinforcing our patient-centred approach
Redenlab are thrilled to announce that Dr. Peter Gibilisco has joined Redenlab’s advisory board. As a consumer advisor…
Redenlab shines in Huberman Podcast, unveiling cannabis study and speech analysis expertise
MEDIA RELEASERedenlab, a leading techbio company, proudly announces its recent feature on the highly acclaimed Huberman Podcast. The…
Redenlab selected for world-first international collaboration investigating neurofilament light chain and voice for diagnosing dementia
Redenlab are partnering with Monash university, University of Melbourne, Eastern Health, and Invicta to deliver this world-first collaboration…
Simons Searchlight: Researcher Profile: Angela Morgan, PhD
Angela Morgan, PhD, is a National Health and Medical Research Council Elizabeth Blackburn Fellow and leads the Speech…
The L16HTHOUSE Study
L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays…
Dietary fat supplement trial for A-T
Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts…
Temporary Assessment of Language in Kabuki Syndrome (TALK) Study
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate…
How speech analytics is revolutionizing the monitoring and diagnosis of neurological disorders
Speech analytics is a rapidly evolving technology that is transforming the field of digital medicine by providing advanced…
ARIAS: Zooming in on eye-based biomarkers for Alzheimer’s
Scientists are turning to retinas as a potential screening target for early signs of Alzheimer’s, an incurable neurodegenerative…
Redenlab partners with Curebase to expand data capture capabilities in pharma trials
Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab,…
Redenlab’s Professor Angela Morgan appears on Network 7’s House of Wellness to discuss ground-breaking international study on stuttering
MEDIA RELEASEFRIDAY 15 JULY 2022 As many as 70% of people who experience stuttering have a family member…
CLOSED: Marketing Specialist
Marketing Specialist – REMOTE/WFH DescriptionThe Marketing Specialist will support, improve, and implement technologies, systems, and processes for…
Redenlab strengthens its reach in linguistic/language analytics with appointment of eminent neuroscientist Prof Adolfo Garcia
Dr Garcia joins the Redenlab science team to drive its language analytics pipeline for cognitive-linguistic disorders like fronto-temporal…
CLOSED: Project Manager
We’re a speech science organisation focused on advancing the development of new treatments and enabling earlier clinical insights…
Redenlab release 2nd generation iOS product on the App Store
Redenlab’s latest iOS application provides state of the art audio capture, storage and analysis of speech and language…
Redenlab is supporting a study sponsored by the Australian Department of Defence on ‘Enhancing decision making through speech biometrics’
Redenlab is contributing to a study sponsored by the Australian Department of Defence and The University of Melbourne…
Redenlab brings on Dr Amir Lahav as Chief of Digital Health and Strategy
Dr Amir Lahav hired as Chief of Digital Health and Strategy. He is a clinical neuroscientist and a…
CLOSED: Quality Assurance Associate at Redenlab
The Position Redenlab is seeking an experienced Quality Assurance Associate to join our growing Regulatory Affairs & Quality…
Redenlab appoints eminent statistician Prof Geoff Stuart to lead its Statistics team
Dr Geoff Stuart joins the Redenlab analytics team as Statistics Director. Geoff will be running the company’s clinical…
Redenlab working as industry partner supporting a successful Australian Research Council Training Centre for Optimal Ageing
Redenlab are part of a successful consortium securing funding for training a new cohort of early career researchers…
Redenlab awarded new clinical trial with Top 10 Pharma company
Redenlab Inc. are pleased to announce securing clinical trial in Cyclic Vomiting Syndrome with a Top 10 pharma…
Recognition for one of Australia’s top clinical medicine scientists, Professor Angela Morgan
Professor Angela Morgan has been recognised for her outstanding leadership in advancing the diagnosis, prognosis and management of…
Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?
Redenlab CSO, Adam Vogel, will be presenting at the upcoming ERN-RND joint webinar with the European Acadamy of…
CLOSED – Job Opportunity: Software Developer.
The Position Redenlab is seeking an experienced Software Developer. Redenlab is one of the world’s leading providers of…
SpeechATAXIA- a multinational, multilanguage consortia for speech in hereditary ataxias – powered by Redenlab
SpeechATAXIA is a multi-language, multi-national, multi-ataxia consortia designed to measure communication change over time.
Redenlab supporting new randomized parallel group, placebo-controlled, dose-escalation clinical trial in Ataxia Telangiectasia
Redenlab are proud to support an upcoming randomized parallel group, placebo-controlled, dose-escalation clinical trial in Ataxia Telangiectasia
Introducing Redenlab’s new Science Lead, Dr Gustavo Noffs MD, PhD
Welcome Dr Noffs. Gustavo brings a wealth of clinical and research experience to the team, making contributions to…
Redenlab is supporting a new long term open label extension study in Friedreich ataxia
Redenlab Inc. are excited to announce securing another clinical trial in Friedreich ataxia. Redenlab are providing speech analytics…
Redenlab chosen for new multinational natural history study in Dentatorubral-pallidoluysian atrophy (DRPLA)
Redenlab Inc, the speech neuroscience company delivering insights in communication testing, announces that it has been selected by…
Redenlab supporting Larimar Therapeutics in Phase 1 SAD Clinical Trial
Redenlab are glad to be supporting Larimar Therapeutics Inc. Phase 1 SAD clinical trial is a double-blind, placebo-controlled,…
Redenlab supporting PTC Theraputics in Global Phase 3 Clinical Trial
Redenlab are proud to be supporting PTC Therapeutics, Inc. Global Phase 3 Clinical Trial to Evaluate Vatiquinone in…
Redenlab featured in Comalatech case study
Learn more about the platforms and applications that Redenlab use for software development, documentation, and quality management that…
Redenlab – Global Experts
We are excited to announce that Redenlab Speech Scientists ranked top 1 AND 2 in the world for…
Redenlab joins global Friedreich ataxia collaboration
Redenlab has entered into a 5 year collaboration with investigators from North and South America, Australia and Europe…
How important is stability in your speech measures?
In our new study, published in the Journal of Acoustical Society of America, we tested reliability, stability, and…
Redenlab presenting work on speech in ataxia & Parkinson’s disease at Movement Disorders Congress in Nice, France – September 2019
Redenlab scientists will be presenting at the upcoming meetings of #SPATAX & #MDSCongress in France on utility of…
Exploring the speech and language of individuals with non‐syndromic submucous cleft palate: a preliminary report
BackgroundSubmucous cleft palate (SMCP) has a heterogeneous presentation and is often identified late or misdiagnosed. Diagnosis is prompted…
Redenlab partner with Murdoch Childrens Research Institute in pediatric digital speech testing project
Prof Angela Morgan of Murdoch Childrens Research Institute with Prof Barbara Dodd, partnering with Redenlab receive funding from…
Redenlab commence collaboration with UCSF Memory and Aging Center
Working with clinician-scientists from UCSF Memory and Aging Center, Redenlab are providing services to help track changes in…
Redenlab sign agreement with Monash Institute of Cognitive and Clinical Neurosciences
Redenlab are working with the Monash University Sleep group
Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis
In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an…
Redenlab sign contract with Koneksa Health & Takeda Pharmaceuticals
Redenlab are partnering with Koneksa Health to provide speech testing to Takeda Pharmaceuticals USA on a multi-site trial…
Latest Events
International Congress for Ataxia Research 2024
Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for…
Redenlab at the 2nd Annual Lysosomal Disease Summit 2024
Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be…
Redenlab at the Digital Health and AI Innovation Summit 2024
Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy…
Redenlab at the 14th International Conference on Frontotemporal Dementias (ICFTD), 19 – 22 September 2024
Redenlab is proud to announce our participation in the 14th International Conference on Frontotemporal Dementias (ICFTD), to be…
Interview with Experts (2022) | Professor Adam Vogel
This video features an interview hosted by Global Health Youth Connect with Professor Adam Vogel called Interview with…
Redenlab at the 39th Annual HDSA – May 30 – June 1
Join Redenlab at the upcoming Huntington’s Disease Society of America (HDSA) National Convention, starting on the 30th of…
2023 Digital Health Innovation in Clinical Trials, Drug Development and Mobile Healthcare: June 6 – 7, 2023
Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development…
2022 Kabuki Syndrome Foundation Virtual Conference: October 26 – 27, 2022
The 4th Annual Kabuki Syndrome Foundation Research Conference to be held virtually on Friday, November 4, 2022. The…
International Congress for Ataxia Research: November 1 – 4, 2022
The inaugural International Congress for Ataxia Research will be held on 1 – 4 November, Dallas. Featured topics…
Redenlab presenting at upcoming INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS
Redenlab are presenting some of their work on Parkinson’s Disease and speech at the upcoming virtual Movement Disorders…
Prof Angela Morgan (Pediatric Lead at Redenlab) presenting at Molecular Anthropology of Language Symposium in Zurich
Over the past two decades, genomic studies have played an increasingly important role in exploring the history of…
Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?
Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for…
Symposia on ‘Facial and Vocal Activity as Transdiagnostic Markers of CNS Illness and Treatment Response’ at the 2021 Society of Biological Psychiatry Annual Meeting April 29 through May 01, 2021
Redenlab’s Chief Science Officer (Prof Adam Vogel) presents at the symposia on Facial and Vocal Markers of CNS…
Redenlab selected to support a pivotal Phase 2a gene therapy trial in Friedreich ataxia
Redenlab Inc, the speech neuroscience company delivering insights in speech and language testing, announces that it has been…
SCA & ARCA Global Conference 2020, 19-21 October 2020
SCA Global is a worldwide initiative for clinical research in spinocerebellar ataxias. Redenlab founder Adam Vogel will be…
EMBL -EBI: Virtual Event, Tuesday 10th November 2020
Background & Motivation• Digital Endpoints/Biomarkers based on mobile devices and sensor technology are currentlybeing investigated in many clinical…
HSG 2020: HD in Focus, October 29-31, 2020
The Huntington Study Group is taking the early and proactive step of moving this year’s annual meeting, HSG…
Recent publications
Working alongside leading hospitals and research teams worldwide, we’re developing new approaches to patient care and accelerating scientific discovery. Our technology has supported thousands of published studies. Below you’ll find a curated selection.
Showing 111 publications
Examination of speech processing in noise reveals cognitive deficits in early Huntington’s disease
Struggling to follow a conversation in noise could be more than just annoying, it might signal…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia
A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults
Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
What can speech tell us about pain?
Pain is deeply personal, yet universally expressed through speech. But what if speech isn’t just a…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
Understanding speech and language in KIF1A-associated neurological disorder
A new study published in the European Journal of Human Genetics provides the first systematic analysis…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration
MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a…
Here goes your text ... Select any part of your text to access the formatting toolbar.
Read more
